Literature DB >> 21729285

Structural valve deterioration of a mitral Carpentier-Edwards pericardial bioprosthesis in an 87-year-old woman 16 years after its implantation.

Hiroshi Ito1, Kensuke Sakata, Takashi Haruki, Yurio Kobayashi.   

Abstract

The second-generation pericardial valve, the Carpentier-Edwards perimount bioprosthetic (CEP) valve, shows dramatically improved durability as compared to the first-generation pericardial valve, and excellent performance has been obtained, in both the aortic and mitral positions. Especially in elderly patients with an implanted CEP valve, reoperation due to structural valve deterioration (SVD) is rarely required. Here, we report the case of an 87-year-old woman with an explanted CEP valve in the mitral position due to SVD, 16 years after its implantation.

Entities:  

Mesh:

Year:  2011        PMID: 21729285      PMCID: PMC3149574          DOI: 10.1186/1749-8090-6-88

Source DB:  PubMed          Journal:  J Cardiothorac Surg        ISSN: 1749-8090            Impact factor:   1.637


  8 in total

1.  Reoperative valve surgery in the elderly: predictors of risk and long-term survival.

Authors:  Leora B Balsam; Eugene A Grossi; David G Greenhouse; Patricia Ursomanno; Abelardo Deanda; Greg H Ribakove; Alfred T Culliford; Aubrey C Galloway
Journal:  Ann Thorac Surg       Date:  2010-10       Impact factor: 4.330

2.  Structural valve deterioration in mitral replacement surgery: comparison of Carpentier-Edwards supra-annular porcine and perimount pericardial bioprostheses.

Authors:  W R Eric Jamieson; M A Marchand; C L Pelletier; R Norton; M Pellerin; T W Dubiel; M R Aupart; W J Daenen; M P Holden; T E David; E A Ryba; W N Anderson
Journal:  J Thorac Cardiovasc Surg       Date:  1999-08       Impact factor: 5.209

3.  Hemodynamic performance of the Medtronic Mosaic porcine bioprosthesis up to ten years.

Authors:  Friedrich-Christian Riess; Ralf Bader; Eva Cramer; Lorenz Hansen; Bèr Kleijnen; Gunther Wahl; Jürgen Wallrath; Stephan Winkel; Niels Bleese
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

4.  Twenty-two year experience with the omniscience prosthetic heart valve.

Authors:  Yoshio Misawa; Masanobu Taguchi; Kei Aizawa; Hideki Takahashi; Yasuhito Sakano; Yuichiro Kaminishi; Shin-Ichi Oki; Hiroaki Konishi; Tsutomu Saito; Morito Kato
Journal:  ASAIO J       Date:  2004 Nov-Dec       Impact factor: 2.872

5.  Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis.

Authors:  M A Marchand; M R Aupart; R Norton; I R Goldsmith; L C Pelletier; M Pellerin; T Dubiel; W J Daenen; P Herijgers; F P Casselman; M P Holden; T E David
Journal:  Ann Thorac Surg       Date:  2001-05       Impact factor: 4.330

6.  Bioprosthetic and mechanical valves in the elderly: benefits and risks.

Authors:  K Holper; M Wottke; T Lewe; L Baumer; H Meisner; S U Paek; F Sebening
Journal:  Ann Thorac Surg       Date:  1995-08       Impact factor: 4.330

7.  Optimal oral anticoagulant therapy in patients with mechanical heart valves.

Authors:  S C Cannegieter; F R Rosendaal; A R Wintzen; F J van der Meer; J P Vandenbroucke; E Briët
Journal:  N Engl J Med       Date:  1995-07-06       Impact factor: 91.245

8.  A case of Carpentier-Edwards pericardial bioprosthesis in mitral position explanted 22 years after implantation.

Authors:  Suguru Kubota; Satoru Wakasa; Tomonori Ooka; Tsuyoshi Tachibana; Norihiko Shiiya; Yoshiro Matsui
Journal:  J Artif Organs       Date:  2010-02-17       Impact factor: 1.731

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.